Evidence-based clinical practice guidelines for chronic pancreatitis 2015

详细信息    查看全文

• 作者：Tetsuhide Ito ; Hiroshi Ishiguro ; Hirotaka Ohara…
• 关键词：Chronis pancreatitis ; Guidelines ; GRADE system ; Early stage chronic pancreatitis ; Pancreatic exocrine ; Pancreatic endocrine ; Pancreatic dysfunction ; Pain management ; Medical conservative therapy ; Surgical therapy
• 刊名：Journal of Gastroenterology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：51
• 期：2
• 页码：85-92
• 全文大小：699 KB
• 参考文献：1.Shimosegawa T, Kataoka K, Kamisawa T, et al. The revised Japanese clinical diagnostic criteria for chronic pancreatitis. J Gastroenterol. 2010;45:584–91.CrossRef PubMed
  2.Schünemann HJ, Oxman AD, Brozek J, et al. GRADE: assessing the quality of evidence for diagnostic recommendations. Evid Based Med. 2008;13:162–3.CrossRef PubMed
  3.Schünemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106–10.PubMedCentral CrossRef PubMed
  4.Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.PubMedCentral CrossRef PubMed
  5.Pezzilli R, Talamini G, Gullo L. Behavior of serum pancreatic enzymes in chronic pancreatitis. Dig Liver Dis. 2000;32:233–7.CrossRef PubMed
  6.Ventrucci M, Gullo L, Daniele C, et al. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease. Digestion. 1983;28:114–21.CrossRef PubMed
  7.Ammann RW, Muench R, Otto R, et al. Evolution and regression of pancreatic calcification in chronic pancreatitis: a prospective long-term study of 107 patients. Gastroenterology. 1988;95:1018–28.PubMed
  8.Buscail L, Escourrou J, Moreau J, et al. Endoscopic ultrasonography in chronic pancreatitis: a comparative prospective study with 8 conventional ultrasonography, computed tomography, and ERCP. Pancreas. 1995;10:251–7.CrossRef PubMed
  9.Rosch T, Schusdziarra V, Born P, et al. Modern imaging methods versus clinical assessment in the evaluation of hospital in-patients with suspected pancreatic disease. Am J Gastroenterol. 2000;95:2261–70.CrossRef PubMed
  10.Bozkurt T, Braun U, Leferink S, et al. Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis. Gut. 1994;35:1132–6.PubMedCentral CrossRef PubMed
  11.Sanyal R, Stevens T, Novak E, et al. Secretin-enhanced MRCP: review of technique and application with proposal for quantification of exocrine function. AJR Am J Roentgenol. 2012;198:124–32.CrossRef PubMed
  12.Catalano MF, Lahoti S, Geenen JE, et al. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc. 1998;48:11–7.CrossRef PubMed
  13.Wiersema MJ, Hawes RH, Lehman GA, et al. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy. 1993;25:555–64.CrossRef PubMed
  14.Buscail L, Escourrou J, Moreau J, et al. Endoscopic ultrasonography in chronic pancreatitis: a comparative prospective study with conventional ultrasonography, computed tomography, and ERCP. Pancreas. 1995;10:251–7.CrossRef PubMed
  15.Mikata R, Ishihara T, Tada M, et al. Clinical usefulness of repeated pancreatic juice cytology via endoscopic naso-pancreatic drainage tube in patients with pancreatic cancer. J Gastroenterol. 2013;48:866–73.CrossRef PubMed
  16.Kataoka K, Yamane Y, Kato M, et al. Diagnosis of chronic pancreatitis using noninvasive tests of exocrine pancreatic function: comparison to duodenal intubation tests. Pancreas. 1997;15:409–15.CrossRef PubMed
  17.Stasi MD, Lencioni R, Solmi L, et al. Ultrasound-guided fine needle biopsy of pancreatic masses: results of a multicenter study. Am J Gastroenterol. 1998;93:1329–33.CrossRef PubMed
  18.Tanno S, Nakano Y, Koizumi K, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010;39:36–40.CrossRef PubMed
  19.Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: guideline for indication, counseling, consent and privacy issues. Pancreatology. 2001;1:405–15.CrossRef PubMed
  20.Teich N, Mossner J. Hereditary chronic pancreatitis. Best Pract Res Clin Gastroenterol. 2008;22:115–30.CrossRef PubMed
  21.Ammann RW. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas. 1997;14:215–21.CrossRef PubMed
  22.Ramesh H. Proposal for a new grading system for chronic pancreatitis. J Clin Gastroenterol. 2002;35:67–70.CrossRef PubMed
  23.Ventrucci M, Gullo L, Daniele C, et al. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease. Digestion. 1983;28:114–21.CrossRef PubMed
  24.Kamisawa T, Matsukawa M, Yoshiike M, et al. Chronic pancreatitis progressing from segmental lesions. Hepatogastroenterology. 2005;52:1255–8.PubMed
  25.Otsuki M. Chronic pancreatitis: the problems of diagnostic criteria. Pancreatology. 2004;4:28–41.CrossRef PubMed
  26.Catalano MF, Sahai A, Levy M, et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009;69:1251–61.CrossRef PubMed
  27.Kitagawa M, Naruse S, Ishiguro H, et al. Evaluating exocrine function tests for diagnosing chronic pancreatitis. Pancreas. 1997;15:402–8.CrossRef PubMed
  28.Kataoka K, Yamane Y, Kato M, et al. Diagnosis of chronic pancreatitis using noninvasive tests of exocrine pancreatic function: comparison to duodenal intubation tests. Pancreas. 1997;15:409–15.CrossRef PubMed
  29.Hayakawa T, Kondo T, Shibata T. Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis. Am J Gastroenterol. 1992;87:1170–4.PubMed
  30.Koizumi M, Yoshida Y, Abe N, et al. Pancreatic diabetes in Japan. Pancreas. 1998;16:385–91.CrossRef PubMed
  31.Chari ST, Singer MV. The problem of classification and staging of chronic pancreatitis. Scand J Gastroenterol. 1994;29:949–60.CrossRef PubMed
  32.Schneider A, Löhr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol. 2007;42:101–19.CrossRef PubMed
  33.Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707.CrossRef PubMed
  34.Axon AT, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis: international definitions. Gut. 1984;25:1107–12.PubMedCentral CrossRef PubMed
  35.Ammann RW. Diagnosis and management of chronic pancreatitis: current knowledge. Swiss Med Wkly. 2006;136:166–74.PubMed
  36.Nakamura T, Takeuchi T, Tando Y. Pancreatic dysfunction and treatment options. Pancreas. 1998;16:329–36.CrossRef PubMed
  37.Marotta F, O’Keefe SJ, Marks IN, et al. Pancreatic enzyme replacement therapy: importance of gastric acid secretion, H2-antagonists, and enteric coating. Dig Dis Sci. 1989;34:456–61.CrossRef PubMed
  38.Lankisch PG. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis. Digestion. 1993;54(Suppl 2):21–9.CrossRef PubMed
  39.Layer P, Keller J, Lankisch PG. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep. 2001;3:101–8.CrossRef PubMed
  40.Nakamura T, Arai Y, Tando Y, et al. Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancreatitis. Clin Ther. 1995;17:448–59.CrossRef PubMed
  41.Lankisch PG. Acute and chronic pancreatitis: an update on management. Drugs. 1984;28:554–64.CrossRef PubMed
  42.Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in patients with acute and chronic pancreatitis. Gastroenterol Clin North Am. 1999;28:695–707.CrossRef PubMed
  43.Perry RS, Gallagher J. Management of maldigestion associated with pancreatic insufficiency. Clin Pharm. 1985;4:161–9.PubMed
  44.Kawabe K, Ito T, Igarashi H, et al. The current managements of pancreatic diabetes in Japan. Clin J Gastroenterol. 2009;2:1–8.CrossRef PubMed
  45.Ito T, Otsuki M, Igarashi H, et al. Epidemiological study of pancreatic diabetes in Japan in 2005: a nationwide study. Pancreas. 2010;39:829–35.CrossRef PubMed
  46.Daniel JD, Michael AN. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368:1969–75.
  47.Elashoff M, Matveyenko AV, Gier B, et al. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology. 2011;141:150–6.PubMedCentral CrossRef PubMed
  48.Butler PC, Elashoff M, Elahoff R, et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care. 2013;36:2118–25.PubMedCentral CrossRef PubMed
  49.Dore DD, Hussein M, Hoffman C, et al. A pooled analysis of exenatide use and risk of acute pancreatitis. Curr Med Res Opin. 2013;29:1577–86.CrossRef PubMed
  50.Nauck MA. A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks. Diabetes Care. 2013;36:2126–32.PubMedCentral CrossRef PubMed
  51.Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–11.CrossRef PubMed
  52.Varadarajulu S, Bang JY, Sutton BS, et al. Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial. Gastroenterology. 2013;145:583–90.CrossRef PubMed
  53.Nealon WH, Walser E. Duct drainage alone is sufficient in the operative management of pancreatic pseudocyst in patients with chronic pancreatitis. Ann Surg. 2003;237:614–20.PubMedCentral PubMed
  54.Schlosser W, Siech M, Beger HG. Pseudocyst treatment in chronic pancreatitis: surgical treatment of the underlying disease increases the long-term success. Dig Surg. 2005;22:340–5.CrossRef PubMed
  55.Olakowski M, Mieczkowska-Palacz H, Olakowska E, et al. Surgical management of pancreaticopleural fistulas. Acta Chir Belg. 2009;109:735–40.PubMed
  56.Tajima Y, Tsutsumi R, Kuroki T, et al. Evaluation and management of thoracopancreatic fistula. Surgery. 2006;140:773–8.CrossRef PubMed
  57.Ohge H, Yokoyama T, Kodama T, et al. Surgical approaches for pancreatic ascites: report of three cases. Surg Today. 1999;29:458–61.CrossRef PubMed
  58.Dumonceau JM, Tringali A, Blero D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:277–89.CrossRef PubMed
  59.Lermite E, Regenet N, Tuech JJ, et al. Diagnosis and treatment of hemosuccus pancreaticus: development of endovascular management. Pancreas. 2007;34:229–32.CrossRef PubMed
  60.Inui K, Tazuma S, Yamaguchi T, et al. Treatment of pancreatic stones with extracorporeal shock wave lithotripsy. Pancreas. 2005;30:26–30.PubMed
  61.Ohara H, Hoshino M, Hayakawa T, et al. Single application extracorporeal shock wave lithotripsy is the first choice for patients with pancreatic duct stones. Am J Gastroenterol. 1996;91:1388–94.PubMed
  62.Sauerbruch T, Holl J, Paumgartner G. Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain: a prospective follow up study. Gut. 1992;33:969–72.PubMedCentral CrossRef PubMed
  63.Hayakawa T, Kondo T, Shibata T, et al. Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis. Digestion. 1993;54:148–55.CrossRef
  64.Lankisch PG, Lohr-Happe A, Otto J, et al. Natural course in chronic pancreatitis. Digestion. 1993;54:148–55.CrossRef PubMed
  65.Miyake H, Harada H, Kunichika K, et al. Clinical course and prognosis of chronic pancreatitis. Pancreas. 1987;2:378–85.CrossRef PubMed
  66.Andriulli A, Botteri E, Almasio PL, et al. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas. 2010;39:1205–10.CrossRef PubMed
  67.Cavallini G, Talamini G, Vaona B, et al. Effect of alcohol and smoking on pancreatic lithogenesis in the course of chronic pancreatitis. Pancreas. 1994;9:42–6.CrossRef PubMed
  68.Imoto M, DiMagno EP. Cigarette smoking increases the risk of pancreatic calcification in late-onset but not early-onset idiopathic chronic pancreatitis. Pancreas. 2000;21:115–9.CrossRef PubMed
  69.Kanoh M, Ibata H, Miyagawa M, et al. Clinical effects of camostat in chronic pancreatitis. Biomed Res. 1989;10(Suppl 1):145–50.
  70.Cahen DL, Gouma DJ, Laramée P, et al. Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology. 2011;141:1690–5.CrossRef PubMed
  71.Dumonceau JM, Delhaye M, Tringali A, et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2012;44:784–800.CrossRef PubMed
  72.Kataoka K, Sakagami J, Hirota M, et al. Effects of oral ingestion of the elemental diet in patients with painful chronic pancreatitis in the real-life setting in Japan. Pancreas. 2014;43:451–7.CrossRef PubMed
  73.Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer: international Pancreatitis Study Group. N Engl J Med. 1993;328:1433–7.CrossRef PubMed
  74.Kamisawa T, Tu Y, Egawa N, et al. The incidence of pancreatic and extrapancreatic cancers in Japanese patients with chronic pancreatitis. Hepatogastroenterology. 2007;54:1579–81.PubMed
  75.Capurso G, Falconi M, Panzuto F, et al. Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients. Am J Gastroenterol. 2009;104:3034–304.CrossRef PubMed
  76.Lankisch MR, Imoto M, Layer P, et al. The effect of small amounts of alcohol on the clinical course of chronic pancreatitis. Mayo Clin Proc. 2001;76:242–51.CrossRef PubMed
  77.Arvanitakis M, Van Laethem JL, Parma J, et al. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation. Endoscopy. 2004;36:535–42.CrossRef PubMed
  78.Löhr M, Müller P, Mora J, et al. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis. Gastrointest Endosc. 2001;53:734–43.CrossRef PubMed
  79.Nojgaard C, Bendtsen F, Becker U, et al. Danish patients with chronic pancreatitis have a four-fold higher mortality rate than the Danish population. Clin Gastroenterol Hepatol. 2010;8:384–90.CrossRef PubMed
  80.Lankisch PG, Löhr-Happe A, Otto J, et al. Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion. 1993;54:148–55.CrossRef PubMed
  81.Knop FK, Vilsboll T, Larsen S, et al. No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis. Diabetes Care. 2003;26:2581–7.CrossRef PubMed
  
• 作者单位：Tetsuhide Ito (1)
  Hiroshi Ishiguro (1)
  Hirotaka Ohara (1)
  Terumi Kamisawa (1)
  Junichi Sakagami (1)
  Naohiro Sata (1)
  Yoshifumi Takeyama (1)
  Morihisa Hirota (1)
  Hiroyuki Miyakawa (1)
  Hisato Igarashi (1)
  Lingaku Lee (1)
  Takashi Fujiyama (1)
  Masayuki Hijioka (1)
  Keijiro Ueda (1)
  Yuichi Tachibana (1)
  Yoshio Sogame (1)
  Hiroaki Yasuda (1)
  Ryusuke Kato (1)
  Keisho Kataoka (1)
  Keiko Shiratori (1)
  Masanori Sugiyama (1)
  Kazuichi Okazaki (1)
  Shigeyuki Kawa (1)
  Yusuke Tando (1)
  Yoshikazu Kinoshita (1)
  Mamoru Watanabe (1)
  Tooru Shimosegawa (1)
  
  1. Guidelines Committee for creating and evaluating the “Evidence-based clinical practice guidelines for chronic pancreatitis”, The Japanese Society of Gastroenterology (JSGE), K-18 Building 8F, 8-9-13. Ginza, Chuo, Tokyo, 104-0061, Japan
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Gastroenterology
  Oncology
  Surgical Oncology
  Hepatology
  Internal Medicine
  Colorectal Surgery
  
• 出版者：Springer Japan
• ISSN：1435-5922

文摘

Chronic pancreatitis is considered to be an irreversible progressive chronic inflammatory disease. The etiology and pathology of chronic pancreatitis are complex; therefore, it is important to correctly understand the stage and pathology and provide appropriate treatment accordingly. The newly revised Clinical Practice Guidelines of Chronic Pancreatitis 2015 consist of four chapters, i.e., diagnosis, staging, treatment, and prognosis, and includes a total of 65 clinical questions. These guidelines have aimed at providing certain directions and clinically practical contents for the management of chronic pancreatitis, preferentially adopting clinically useful articles. These revised guidelines also refer to early chronic pancreatitis based on the Criteria for the Diagnosis of Chronic Pancreatitis 2009. They include such items as health insurance coverage of high-titer lipase preparations and extracorporeal shock wave lithotripsy, new antidiabetic drugs, and the definition of and treatment approach to pancreatic pseudocyst. The accuracy of these guidelines has been improved by examining and adopting new evidence obtained after the publication of the first edition. Keywords Chronis pancreatitis Guidelines GRADE system Early stage chronic pancreatitis Pancreatic exocrine Pancreatic endocrine Pancreatic dysfunction Pain management Medical conservative therapy Surgical therapy